FOXO3 and breast cancer: It has been shown that sEVs transferred miR-155 into MCF-7 and MDA-MB-231 BC cells, where it upregulates EMT marker molecules, targets mRNAs of TGF-β and FOXO-3a and confers C/EBP-β-induced BC resistance [166].